Drug	Gene	Type	Source
20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13.alpha.,14.alpha.)-	CYP2C19	Text_Mining(increases(activity))	CTD
20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13.alpha.,14.alpha.)-	CYP2C19	Text_Mining(increases(metabolic processing))	CTD
20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13.alpha.,14.alpha.)-	CYP3A4	Text_Mining(increases(activity))	CTD
20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13.alpha.,14.alpha.)-	CYP3A4	Text_Mining(increases(metabolic processing))	CTD
20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13.alpha.,14.alpha.)-	SLC22A1	Text_Mining(decreases(reaction))	CTD
20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13.alpha.,14.alpha.)-	SLC22A1	Text_Mining(increases(uptake))	CTD
20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13.alpha.,14.alpha.)-	SLC6A4	Text_Mining(increases(expression))	CTD
20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13.alpha.,14.alpha.)-	SLC6A4	Text_Mining(decreases(reaction))	CTD
20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13.alpha.,14.alpha.)-	CFTR	None=None(uM)	D4 PubChem
20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13.alpha.,14.alpha.)-	GOPC	None=None(uM)	D4 PubChem
20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13.alpha.,14.alpha.)-	NR0B1	None=None(uM)	D4 PubChem
20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13.alpha.,14.alpha.)-	TDP1	Potency=5.8048(uM)	D4 PubChem
20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13.alpha.,14.alpha.)-	TDP1	Potency=11.5821(uM)	D4 PubChem
20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13.alpha.,14.alpha.)-	TRHR	None=None(uM)	D4 PubChem